603229 Share Price Performance
CN¥10.20
1.03 (11.23%)
Price CN¥10.20
Share PriceCN¥10.20
What Zhejiang Ausun Pharmaceutical Co., Ltd.'s (SHSE:603229) 28% Share Price Gain Is Not Telling You
Jan 06
Zhejiang Ausun Pharmaceutical Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
603229 Community Narratives
There are no narratives available yet.
Zhejiang Ausun Pharmaceutical Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 31, 2025
- Earnings per share (EPS)
- 0.24
- Gross Margin
- 51.96%
- Net Profit Margin
- 25.01%
- Debt/Equity Ratio
- 13.6%
Zhejiang Ausun Pharmaceutical Co., Ltd. Competitors
Snowflake Analysis
About 603229
- Founded
- 2010
- Employees
- 1219
- CEO
- WebsiteView website
Zhejiang Ausun Pharmaceutical Co., Ltd. engages in the research and development, process development, manufacture, and sale of APIs and pharmaceutical intermediates. It offers fluorine products, prostaglandins, antimicrobials, and oncology products. The company also provides products for liver disease, respiratory system, and cardiac and cerebral vessels, as well as CNS indications. In addition, it offers development and manufacturing services to the pharmaceutical, cosmetics, and nutritional industries. The company was founded in 2010 and is based in Linhai, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 0.5%
- 3 Months: 17.0%
- 1 Year: 24.1%
- Year to Date: 26.2%
Over the last 7 days, the market has remained flat, with no particular sector making any big moves this week. As for the longer term, the market has risen 24% in the past 12 months. Earnings are forecast to grow by 27% annually. Market details ›